Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by IgE
hyperproduction and eosinophilic inflammation. The anti-IgE antibody, omalizumab, has …

Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory condition of the
paranasal sinuses and nasal passage. It is characterized as inflammation of the sinonasal …

Chronic rhinosinusitis is a common inflammatory disease of paranasal sinuses, which
causes rhinorrhea, nasal congestion, and hyposmia. The genetic predisposition or the …

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) and type 2 asthma share
the same inflammatory pathophysiology and are frequent comorbidities. Dupilumab, a fully …

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous
disease with variable underlying pathophysiologies. Numerous patient factors have been …

Background Chronic rhinosinusitis is regarded as a chronic airway disease. According to
WHO recommendations, it may be a risk factor for COVID‐19 patients. In most CRSwNP …

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) often requires surgery, but
recurrence even after surgery is common. Recurrence rates largely vary in literature and …

The aim of this study was to evaluate the efficacy of mepolizumab in patients affected by
chronic rhinosinusitis with nasal polyps (CRSwNP) in real-life. A single-center retrospective …

Hintergrund Die chronische Rhinosinusitis (CRS) betrifft weltweit ca. 5–12% der
Allgemeinbevölkerung und wird traditionell eingeteilt in einen Phänotyp ohne (CRSsNP) …

Asthma, atopic dermatitis and chronic rhinoconjunctivitis are highly heterogeneous.
However, epidemiologic associations exist between phenotypic groups of patients. Atopic …